Combined anti-Inflammatory and angiostatic treatment as first-or second-line therapy in patients with B-raf negative metastatic melanoma: A combined treatment of temsirolimus with pioglitazone, etoricoxib and low-dose trofosfamide (phase I trial)

Reichle, A. and Vogelhuber, M. and Hart, C. and Hafner, C. and Landthaler, M. and Berneburg, M. and Herr, W. (2014) Combined anti-Inflammatory and angiostatic treatment as first-or second-line therapy in patients with B-raf negative metastatic melanoma: A combined treatment of temsirolimus with pioglitazone, etoricoxib and low-dose trofosfamide (phase I trial). ONCOLOGY RESEARCH AND TREATMENT, 37 (Suppl5). p. 209. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 07 Aug 2020 05:19
Last Modified: 07 Aug 2020 05:19
URI: https://pred.uni-regensburg.de/id/eprint/9425

Actions (login required)

View Item View Item